Literature DB >> 15001274

Treatment planning guidelines regarding the use of CT/PET-guided IMRT for cervical carcinoma with positive paraaortic lymph nodes.

Jacqueline Esthappan1, Sasa Mutic, Robert S Malyapa, Perry W Grigsby, Imran Zoberi, Farrokh Dehdashti, Tom R Miller, Walter R Bosch, Daniel A Low.   

Abstract

PURPOSE: Computed tomography (CT)/positron emission tomography (PET)-guided intensity-modulated radiotherapy of the paraaortic lymph nodes (PALNs) has been proposed for patients with cervical carcinoma and paraaortic metastasis. This investigation attempted to determine the guidelines regarding the selection of appropriate treatment parameters (e.g., number of beams, beam geometry) and organ-specific parameters (e.g., importance weighting and tolerance dose) for intensity-modulated radiotherapy planning for the PALNs. METHODS AND MATERIALS: Patients underwent imaging using CT and PET. The images were registered, and the structures were contoured. A goal dose of 50.4 Gy and 59.4 Gy was assigned to the clinical target volume (lymph node bed) and gross tumor volume (PET-delineated PALNs), respectively. For each patient, multiple treatment plans using various beam geometries and planning parameters were executed and evaluated in terms of the dose-volume histograms of the target and critical structures.
RESULTS: Acceptable sparing of the stomach, liver, and colon was achieved, regardless of the number of beams used. Sparing of the spinal cord was strongly dependent on the number and arrangement of the beams. Varying the number and arrangement of the beams affected small intestine sparing, but the amount of sparing was limited because the small intestine overlapped the target volumes, and, therefore, received the prescription dose. Adjusting the number of beams, beam angles, and prescription parameters provided minimal improvement in kidney sparing.
CONCLUSION: We successfully developed treatment plans that deliver 59.4 Gy to the positive PALNs and 50.4 Gy to the paraaortic region using CT/PET-guided intensity-modulated radiotherapy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15001274     DOI: 10.1016/j.ijrobp.2003.09.074

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  11 in total

1.  Survival benefit of laparoscopic surgical staging-guided radiation therapy in locally advanced cervical cancer.

Authors:  Dae Gy Hong; Nae Yoon Park; Gun Oh Chong; Young Lae Cho; Il Soo Park; Yoon Soon Lee
Journal:  J Gynecol Oncol       Date:  2010-09-28       Impact factor: 4.401

2.  A novel dynamic field-matching technique for treatment of patients with para-aortic node-positive cervical cancer: Clinical experience.

Authors:  Craig Baden; Alexander Whitley; Javier López-Araujo; Richard Popple; Jun Duan; Robert Kim
Journal:  Rep Pract Oncol Radiother       Date:  2015-11-21

3.  Clinical Applications of PET and PET-CT.

Authors:  S S Anand; H Singh; A K Dash
Journal:  Med J Armed Forces India       Date:  2011-07-21

Review 4.  Hypoxia imaging-directed radiation treatment planning.

Authors:  J G Rajendran; K R G Hendrickson; A M Spence; M Muzi; K A Krohn; D A Mankoff
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-07       Impact factor: 9.236

5.  18FDG-PET/CT Definition of Clinical Target Volume for Robotic Stereotactic Body Radiosurgery Treatment of Metastatic Gynecologic Malignancies.

Authors:  Charles A Kunos; Robert Debernardo; Jeffrey Fabien; Donald C Dobbins; Yuxia Zhang; James Brindle; Peter F Faulhaber
Journal:  J Nucl Med Radiat Ther       Date:  2011-12-12

6.  Survival outcomes in patients with cervical cancer after inclusion of PET/CT in staging procedures.

Authors:  Henrik Villibald Hansen; Annika Loft; Anne Kiil Berthelsen; Ib Jarle Christensen; Claus Høgdall; Svend Aage Engelholm
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-07-22       Impact factor: 9.236

7.  The role of PET/CT in cervical cancer.

Authors:  Fernanda G Herrera; John O Prior
Journal:  Front Oncol       Date:  2013-02-26       Impact factor: 6.244

Review 8.  The impact of functional imaging on radiation medicine.

Authors:  Nidhi Sharma; Donald Neumann; Roger Macklis
Journal:  Radiat Oncol       Date:  2008-09-15       Impact factor: 3.481

9.  The role of [(18)F]FDG-PET/CT in staging and treatment planning for volumetric modulated Rapidarc radiotherapy in cervical cancer: experience of the European Institute of Oncology, Milan, Italy.

Authors:  Roberta Lazzari; Agnese Cecconi; Barbara A Jereczek-Fossa; Laura Lavinia Travaini; Veronica Dell' Acqua; Federica Cattani; Stefania Rizzo; Cristiana Fodor; Fabio Landoni; Roberto Orecchia
Journal:  Ecancermedicalscience       Date:  2014-03-05

Review 10.  The role of PET-CT in radiotherapy planning of solid tumours.

Authors:  Stasa Jelercic; Mirjana Rajer
Journal:  Radiol Oncol       Date:  2015-03-03       Impact factor: 2.991

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.